Launched in 2018 by the Leducq Trust, Longview Ventures complements the mission-driven investment organization Broadview Ventures by focusing on clinical-stage companies in Series B – Series C financing rounds. Longview Ventures invests in select companies from the Broadview portfolio, with a particular focus on cardiovascular disease and stroke. This allows Longview Ventures to leverage Broadview's expertise in Seed and Series A financings while providing additional funding and support to promising companies in later stages of development.